NCT01085318View on ClinicalTrials.gov

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions
Multiple Sclerosis
Interventions
DRUG

Rebif

44 mcg tiw

Trial Locations (1)

02370

EMD Serono, Inc., Rockland

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT01085318 - Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial | Biotech Hunter | Biotech Hunter